These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1845467)

  • 1. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):129-40. PubMed ID: 1845467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atheroslcerosis. Part I: Principles of classification and methods of dyslipoproteinemia determination.
    Choluj B; Votruba T; Kormúth E
    Acta Univ Carol Med (Praha); 1991; 37(3-4):91-105. PubMed ID: 1845469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):116-28. PubMed ID: 1845466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 5: Normolipidemic (latent) dyslipoproteinemia.
    Choluj B
    Acta Univ Carol Med (Praha); 1991; 37(3-4):141-55. PubMed ID: 1845468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoproteins and lipoproteins of human plasma: significance in health and in disease.
    Kostner GM
    Adv Lipid Res; 1983; 20():1-43. PubMed ID: 6230900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility.
    Hegele RA; Breslow JL
    Genet Epidemiol; 1987; 4(3):163-84. PubMed ID: 2886398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods of biochemical analysis in hyperliproproteinemias].
    Fruchart JC; Clavey V; Vanhoutte G
    Pathol Biol (Paris); 1983 Apr; 31(4):235-45. PubMed ID: 6408590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atherosclerosis and juvenile dyslipidemias].
    Calvani M
    Recenti Prog Med; 1994 Mar; 85(3):204-11. PubMed ID: 8184205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipoproteinemia and diabetes.
    Orchard TJ
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):361-80. PubMed ID: 2192878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipoproteinemias and coronary disease. Genetic markers].
    Sarriá Chueca A; Moreno Aznar L; Bueno Lozano G; Bueno Sánchez M
    An Esp Pediatr; 1989 Jun; 30(6):425-8. PubMed ID: 2572193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoproteins of human plasma high density lipoproteins. Biology, biochemistry and clinical significance.
    Scanu AM; Edelstein C; Gordon JI
    Clin Physiol Biochem; 1984; 2(2-3):111-22. PubMed ID: 6435927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apolipoproteins as risk factors in patients on a regular hemodialysis program].
    Bokan L; Perunicić-Peković G; Rasić-Milutinović Z; Pljesa S; Tepsić V; Ristić V
    Med Pregl; 1997; 50(7-8):293-5. PubMed ID: 9441214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the study of lipoprotein metabolism and atherosclerosis: progress in the molecular genetic study of apolipoproteins and hyperlipidemia].
    Itoh H; Mabuchi H; Takeda R
    Nihon Rinsho; 1988 Mar; 46(3):644-51. PubMed ID: 2900342
    [No Abstract]   [Full Text] [Related]  

  • 16. Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene.
    Nakata K; Kobayashi K; Yanagi H; Shimakura Y; Tsuchiya S; Arinami T; Hamaguchi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):950-5. PubMed ID: 8240372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical significance of apolipoprotein determinations for assessment of the risk of atherosclerosis].
    Gehrisch S; Jaross W; Klement A; Gutschker A; Bergmann S
    Z Med Lab Diagn; 1989; 30(1):37-8. PubMed ID: 2718576
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening, diagnosis, and management of dyslipoproteinemia in children.
    Franklin FA; Brown RF; Franklin CC
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):399-449. PubMed ID: 2192880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The genetic bases of the lipid metabolic disorders in atherosclerosis].
    Tselĭko VI
    Tsitol Genet; 1996; 30(2):74-82. PubMed ID: 9281205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.